Progressive Radio Network

LOA Daily

Gary Null Show Notes - 07.27.21

  1. United Republic Of Soybeans: GMO And Neocolonialism In The Southern Cone

  2. It’s Time For An Urgent Intervention In The Food System Ruining Our Climate

  3. Advocates Condemn Biden Plan to Send 4,000 Inmates Back to Prison After Pandemic

  4. The Continuing Horror of CIA’s Torture and Abuse

  5. Our War Against Nature. Humanity’s March Toward Extinction?

  6. Beware of World Economic Forum/Gates UN Food Systems Summit Trojan Horse

  7. Coronavirus, Vaccines and the Gates Foundation

  8. Opinion: Small farms are the future of food systems 

  9. COVID-19 Vaccine Skeptics Have Many Concerns

  10. Two Studies: COVID-19 Vaccines Trigger Autoimmune Graves’ Disease in Some Female Health Care Workers

  11. More Than Half Of Hospitalized Patients Tested COVID-19 Positive Only After Being Admitted – Leaked NHS Data

  12. Hedges: The Collective Suicide Machine

    Today’s Videos:

    1. An Urgent Message from Professor Dr. Sucharit Bhakdi

    Role of ashwagandha compound in management of Alzheimer disease

    University of Dhaka (Bangladesh), July 23, 2021

    According to news reporting out of Dhaka, Bangladesh, research stated, “Globally, Alzheimer’s disease (AD) is one of the most prevalent age-related neurodegenerative disorders associated with cognitive decline and memory deficits due to beta-amyloid deposition (Ab) and tau protein hyperphosphorylation. To date, approximately 47 million people worldwide have AD.”

    Our news correspondents obtained a quote from the research from University of Dhaka: “This figure will rise to an estimated 75.6 million by 2030 and 135.5 million by 2050. According to the literature, the efficacy of conventional medications for AD is statistically substantial, but clinical relevance is restricted to disease slowing rather than reversal. Withaferin A (WA) is a steroidal lactone glycowithanolides, a secondary metabolite with comprehensive biological effects. Biosynthetically, it is derived from * * Withania somnifera* * (Ashwagandha) and * * Acnistus breviflorus* * (Gallinero) through the mevalonate and non-mevalonate pathways. Mounting evidence shows that WA possesses inhibitory activities against developing a pathological marker of Alzheimer’s diseases. Several cellular and animal models’ particulates to AD have been conducted to assess the underlying protective effect of WA. In AD, the neuroprotective potential of WA is mediated by reduction of beta-amyloid plaque aggregation, tau protein accumulation, regulation of heat shock proteins, and inhibition of oxidative and inflammatory constituents. Despite the various preclinical studies on WA’s therapeutic potentiality, less is known regarding its definite efficacy in humans for AD.”

    According to the news reporters, the research concluded: “Accordingly, the present study focuses on the biosynthesis of WA, the epidemiology and pathophysiology of AD, and finally the therapeutic potential of WA for the treatment and prevention of AD, highlighting the research and augmentation of new therapeutic approaches. Further clinical trials are necessary for evaluating the safety profile and confirming WA’s neuroprotective potency against AD.”

     

    Study finds calcium precisely directs blood flow in the brain

    University of Maryland School of Medicine, July 22, 2021

    Unlike the rest of the body, there is not enough real estate in the brain for stored energy. Instead, the brain relies on the hundreds of miles of blood vessels within it to supply fresh energy via the blood. Yet, how the brain expresses a need for more energy during increased activity and then directs its blood supply to specific hot spots was, until now, poorly understood. 

    Now, University of Maryland School of Medicine and University of Vermont researchers have shown how the brain communicates to blood vessels when in need of energy, and how these blood vessels respond by relaxing or constricting to direct blood flow to specific brain regions.

    In their new paper, published on July 21 in Science Advances, the researchers say that understanding how the brain directs energy to itself in intricate detail can help determine what goes wrong in conditions like Alzheimer’s disease and dementia, where faulty blood flow is a predictor for cognitive impairment. If the brain does not get blood to where it needs it when it needs it, the neurons become stressed, and over time they deteriorate ultimately leading to cognitive decline and memory problems. 

    Large arteries feed medium-sized vessels known as arterioles that then feed even tinier capillaries–so small that only a single blood cell can pass through at once. In a 2017 Nature Neuroscience paper, the researchers showed that electrical pulses coursing through the capillaries direct blood flow from the medium-sized arterioles supplying large regions of the brain. For this latest paper, the team wanted to study the fine-tuning of blood as it flows through the capillaries to precisely regulate energy supply to tiny regions in the brain. 

    “There seem to be two mechanisms working in tandem to ensure that energy in the form of blood makes it to specific regions of the brain: one broad and the other precise,” says Thomas Longden, Ph.D., Assistant Professor of Physiology at University of Maryland School of Medicine. “The first electrical mechanism is like a crude sledgehammer approach to get more blood to the general vicinity of the increased brain activity by controlling the medium-sized arterioles, and then capillary calcium signals ensure exquisite fine-tuning to make sure the blood gets to exactly the right place at the right time through the tiny capillaries.”

    Dr. Longden and his collaborators used a protein which emits green light when calcium increases in the cell. Due to the efforts of Michael Kotlikoff’s team at Cornell University, they were able to turn this tool on in the cells lining blood vessels of mice. The researchers then looked through little windows in the brains of these mice to investigate calcium’s role in controlling blood flow in the brain’s capillaries. When the cells lining the blood vessels received an influx of calcium, they glowed green. They detected 5,000 calcium signals per second in the capillaries in the tiny section of brain visible through the window, which they say amounts to about 1,000,000 of these responses each second in the entire brain’s blood vessel system.

    “Until we deployed this new technology, there was this wholly unseen world of calcium signaling in the brain hidden from view, and now we can see a ton of activity within the brains blood vessels – they are constantly firing,” says Dr. Longden. 

    Dr. Longden and the research team then dissected the intricate cellular mechanism behind calcium’s role in directing blood branch-by-branch through the tiny vessels of the brain. They found that when neurons fire electrical signals, they cause an increase in calcium in the cells lining the blood vessels. Then enzymes detect this calcium and direct the cells to make nitric oxide. Nitric oxide is a hormone (and a gas) that causes muscle-like cells around blood vessels to relax, which then widens the vessels allowing more blood to flow in. 

    “Capillaries were traditionally thought as simple conduits for red blood cells, and the barrier between the blood and brain,” says co-senior author Mark T. Nelson, PhD, University of Vermont Distinguished Professor and Chair of Pharmacology. “Here, we revealed an unknown universe of calcium signaling in capillaries, and much like traffic lights, these calcium signals direct vital nutrients to nearby active neurons.”

    “The first step towards figuring out what goes wrong in diseases is to determine how the system works as it normally should,” says E. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine. “Now that the researchers have a handle on how this process works, they can begin to investigate how the blood flow is disrupted in Alzheimer’s disease and dementia in order to figure out ways to fix it.”

    One in 20 cases of dementia occurs in people under 65

    Mayo Clinic, July 21, 2021

    Dementia is largely a disease of old age, but a new study finds that up to 5% of all cases are among people in the prime of their lives.

    Looking at 95 international studies, researchers estimated that nearly 4 million people worldwide are living with young-onset —cases that strike between the ages of 30 and 64.

    In the United States, an estimated 175,000 people have the condition, accounting for roughly 3% of all dementia cases nationwide.

    In context, that means young-onset dementia is rare, said Dr. David Knopman, a neurologist who specializes in  at the Mayo Clinic in Rochester, Minn.

    But it’s important for people, including doctors, to be aware that dementia can arise unusually early in life, Knopman said.

    Because young-onset dementia is so uncommon, he noted, most doctors—including neurologists—have little or no experience in diagnosing it.

    And since dementia is typically associated with aging, it’s natural to attribute younger people’s memory issues to conditions that are far more common in their age group.

    “Their symptoms are often chalked up to depression or anxiety,” said Knopman, who wrote an editorial published with the study July 19 in JAMA Neurology.

    “And to be fair,” he added, “most memory complaints in younger patients probably are related to those conditions.”

    However, Knopman said, some red flags include symptoms that are “pervasive” and worsen over time. The “breadth” of the symptoms also matters, he noted: “Are there cognitive complaints that go beyond memory lapses?”

    “Cognitive” symptoms include an array of problems related to thinking, reasoning, judgment and learning.

    While young-onset dementia is far less common than the typical “late-onset” form, the disease is particularly devastating. 

    “These people are in the prime of their lives,” Knopman said. They and their spouses have jobs, children and, often, elderly parents to care for.

    That means they need  and other services that meet their specific needs, said Stevie Hendriks, one of the researchers on the new study.

    Given that, Hendriks and colleagues at Maastricht University’s Alzheimer Center Limburg in the Netherlands wanted to get clearer figures on just how many people are living with young-onset dementia.

    After analyzing dozens of previously published studies, they estimated there are 119 cases of young-onset dementia per 100,000 people worldwide. That translates to 3.9 million people living with the disease.

    Based on the global prevalence of dementia, the young-onset form may account for about 5% of all cases, according to Knopman.

    Not surprisingly, Hendriks’ team found, dementia was exceedingly rare among the youngest adults, at roughly 1 case per 100,000 among 30- to 34-year-olds. People in their early 60s had the highest prevalence—about 77 cases per 100,000.

    Unfortunately, people with young-onset dementia typically go for years without a diagnosis. One published study found that it took an average of 4.5 years—versus just under three years among older adults with dementia.

    Hendriks agreed that lack of awareness and experience among doctors likely help explain that.

    But young-onset dementia can also be difficult to diagnose, Hendriks added—even for specialists.

    “We see that the first symptoms in young people are usually not the symptoms you would expect when you think of dementia,” Hendriks said. “Instead of memory impairment, young people more often present with changes in behavior or emotions, or sometimes language problems.”

    That can lead to misdiagnoses of not only depression, but also “burnout” or even relationship problems, Hendriks noted.

    As for the causes of early dementia, they include the same culprits seen in late-onset—namely, Alzheimer’s disease and vascular conditions, like stroke, that impair blood flow to the brain.

    But another rare type of dementia, frontotemporal dementia, is most often diagnosed at a younger age. That disease is inherited in about one-third of cases, according to the Alzheimer’s Association.

    Because young-onset dementia is uncommon, finding specialized services is often a challenge, too, Knopman said. When the time comes for a care facility, for example, it can be hard to find an opening for a younger patient. Families may need to place a loved one in a center hours from home.

    One good resource for families, Knopman said, is their local chapter of the Alzheimer’s Association. Among its services are support groups for caregivers of people with young-onset dementia.

    ‘Good cholesterol’ may protect liver

    Study in mice, human blood samples, suggests HDL from the intestine may prevent liver inflammation

    Washington University School of Medicine, July 26, 2021

    The body’s so-called good cholesterol may be even better than we realize. New research from Washington University School of Medicine in St. Louis suggests that one type of high-density lipoprotein (HDL) has a previously unknown role in protecting the liver from injury. This HDL protects the liver by blocking inflammatory signals produced by common gut bacteria.

    The study is published July 23 in the journal Science.

    HDL is mostly known for mopping up cholesterol in the body and delivering it to the liver for disposal. But in the new study, the researchers identified a special type of HDL called HDL3 that, when produced by the intestine, blocks gut bacterial signals that cause liver inflammation. If not blocked, these bacterial signals travel from the intestine to the liver, where they activate immune cells that trigger an inflammatory state, which leads to liver damage.

    “Even though HDL has been considered ‘good cholesterol,’ drugs that increase overall HDL levels have fallen out of favor in recent years because of clinical trials that showed no benefit in cardiovascular disease,” said senior author Gwendalyn J. Randolph, PhD, the Emil R. Unanue Distinguished Professor of Immunology. “But our study suggests that raising levels of this specific type of HDL, and specifically raising it in the intestine, may hold promise for protecting against liver disease, which, like heart disease, also is a major chronic health problem.” In the study, the researchers showed that HDL3 from the intestine protects the liver from inflammation in mice.

    Any sort of intestinal damage can impact how a group of microbes called Gram-negative bacteria can affect the body. Such microbes produce an inflammatory molecule called lipopolysaccharide that can travel to the liver via the portal vein. The portal vein is the major vessel that supplies blood to the liver, and it carries most nutrients to the liver after food is absorbed in the intestine. Substances from gut microbes may travel along with nutrients from food to activate immune cells that trigger inflammation. In this way, elements of the gut microbiome may drive liver disease, including fatty liver disease and liver fibrosis, in which the liver develops scar tissue.

    Randolph became interested in this topic through a collaboration with two Washington University surgeons, Emily J. Onufer, MD, a surgical resident, and Brad W. Warner, MD, the Jessie L. Ternberg PhD, MD, Distinguished Professor of Pediatric Surgery and chief surgeon at St. Louis Children’s Hospital, both co-authors on the study. Some premature infants develop a life-threatening condition called necrotizing enterocolitis, an inflammation of the intestine that can require a portion of the intestine to be surgically removed. Even after a successful bowel surgery, such babies often develop liver disease, and Onufer and Warner wanted to understand why.

    “They were studying this problem in a mouse model of the condition: They remove a portion of the small intestine in mice and study the liver fibrosis that results,” Randolph said. “There were hints in the literature that HDL might interfere with lipopolysaccharide’s detection by immune cells and that the receptor for lipopolysaccharide might be linked to liver disease following the bowel surgery.

    “However, no one thought that HDL would directly move from the intestine to the liver, which requires that it enter the portal vein,” she said. “In other tissues, HDL travels out through a different type of vessel called a lymphatic vessel that, in the intestine, does not link up to the liver. We have a very nice tool in our lab that lets us shine light on different organs and track the HDL from that organ. So, we wanted to shine light on the intestine and see how the HDL leaves and where it goes from there. That’s how we showed that HDL3 leaves only through the portal vein to go directly to the liver.”

    As the HDL3 makes this short journey down the portal vein, it binds to a protein called LBP — lipopolysaccharide binding protein — which binds to the harmful lipopolysaccharide. When the harmful lipopolysaccharide is bound to this complex, it is blocked from activating immune cells called Kupffer cells. These are macrophages that reside in the liver and, when activated by lipopolysaccharide, can drive liver inflammation.

    As a complex of proteins and fats, HDL3 uses its partnership with LBP to bind to lipopolysaccharide. When LBP is part of the HDL3 complex, it prevents the harmful bacterial molecule from activating the liver Kupffer cells and inducing inflammation, according to experiments conducted by first author Yong-Hyun Han, PhD, when he was a postdoctoral researcher in Randolph’s lab. Han is now on the faculty of Kangwon National University in South Korea.

    “We think that LBP, only when bound to HDL3, is physically standing in the way, so lipopolysaccharide can’t activate the inflammatory immune cells,” Han said. “HDL3 is essentially hiding the harmful molecule. However, if LBP is binding to lipopolysaccharide and HDL3 is not present, LBP is not able to stand in the way. Without HDL3, LBP is going to trigger stronger inflammation.”

    The researchers showed that liver injury is worse when HDL3 from the intestine is reduced, such as from surgical removal of a portion of the intestine.

    “The surgery seems to cause two problems,” Randolph said. “A shorter intestine means it’s making less HDL3, and the surgery itself leads to an injurious state in the gut, which allows more lipopolysaccharide to spill over into the portal blood. When you remove the part of the intestine that makes the most HDL3, you get the worst liver outcome. When you have a mouse that cannot genetically make HDL3, liver inflammation is also worse. We also wanted to see if this dynamic was present in other forms of intestinal injury, so we looked at mouse models of a high-fat diet and alcoholic liver disease.”

    In all of these models of intestinal injury, the researchers found that HDL3 was protective, binding to the additional lipopolysaccharide released from the injured intestine and blocking its downstream inflammatory effects in the liver.

    The researchers further showed that the same protective molecular complexes were present in human blood samples, suggesting a similar mechanism is present in people. They also used a drug compound to increase HDL3 in the intestines of mice and found it to be protective against different types of liver injury. While the drug is only available for animal research, the study reveals new possibilities for treating or preventing liver disease, whether it stems from damage to the intestine caused by high-fat diets, alcohol overuse or physical injury, such as from surgery.

    “We are hopeful that HDL3 can serve as a target in future therapies for liver disease,” Randolph said. “We are continuing our research to better understand the details of this unique process.”

    Vitamin D supplementation may be low-cost supportive care therapy for women with metastatic breast cancer

    Loyola University Chicago, July 19, 2021

    According to news originating from Maywood, Illinois, research stated, “To assess the potential effect of cholecalciferol supplementation to reduce symptom burden for women with metastatic breast cancer (MBC). SAMPLE & SETTING: 11 clinically stable women with estrogen receptor-positive MBC were recruited from a single cancer center for this phase 1, nonrandomized study (NCT02186015).”

    Our news journalists obtained a quote from the research from Loyola University Chicago, “& VARIABLES: Women with insufficient serum 25-hydroxyvitamin D (25[OH]D) levels qualified to receive high-dose repletion therapy. Clinical and questionnaire data on common symptoms and quality of life were obtained prior to and following supplementation. Serum 25(OH)D increased significantly pre-versus postintervention. Trends for improvements in endocrine symptoms, bone pain, and fatigue were observed following the intervention. FOR NURSING: Women achieved normal serum 25(OH)D levels after eight weeks of supplementation and reported reduced symptom burden.”

    According to the news editors, the research concluded: “Vitamin D may be a low-cost supportive care therapy; however, future studies should be considered.”

    This research has been peer-reviewed.

    Lutein may counter cognitive aging, study finds

    University of Illinois, July 25, 2021

    Spinach and kale are favorites of those looking to stay physically fit, but they also could keep consumers cognitively fit, according to a new study from University of Illinois researchers.

    The study, which included 60 adults aged 25 to 45, found that middle-aged participants with higher levels of lutein – a nutrient found in green leafy vegetables such as spinach and kale, as well as avocados and eggs — had neural responses that were more on par with younger individuals than with their peers. The findings were published in the journal Frontiers in Aging Neuroscience.

    “Now there’s an additional reason to eat nutrient-rich foods such as green leafy vegetables, eggs and avocados,” said Naiman Khan, a professor of kinesiology and community health at Illinois. “We know these foods are related to other health benefits, but these data indicate that there may be cognitive benefits as well.”

    Most other studies have focused on older adults, after there has already been a period of decline. The Illinois researchers chose to focus on young to middle-aged adults to see whether there was a notable difference between those with higher and lower lutein levels.

    “As people get older, they experience typical decline. However, research has shown that this process can start earlier than expected. You can even start to see some differences in the 30s,” said Anne Walk, a postdoctoral scholar and first author of the paper. “We want to understand how diet impacts cognition throughout the lifespan. If lutein can protect against decline, we should encourage people to consume lutein-rich foods at a point in their lives when it has maximum benefit.”

    Lutein is a nutrient that the body can’t make on its own, so it must be acquired through diet. Lutein accumulates in brain tissues, but also accumulates in the eye, which allows researchers to measure levels without relying on invasive techniques.

    The Illinois researchers measured lutein in the study participants’ eyes by having participants look into a scope and respond to a flickering light. Then, using electrodes on the scalp, the researchers measured neural activity in the brain while the participants performed a task that tested attention.

    “The neuro-electrical signature of older participants with higher levels of lutein looked much more like their younger counterparts than their peers with less lutein,” Walk said. “Lutein appears to have some protective role, since the data suggest that those with more lutein were able to engage more cognitive resources to complete the task.”

    Next, Khan’s group is running intervention trials, aiming to understand how increased dietary consumption of lutein may increase lutein in the eye, and how closely the levels relate to changes in cognitive performance.

    “In this study we focused on attention, but we also would like to understand the effects of lutein on learning and memory. There’s a lot we are very curious about,” Khan said

    Aerobic exercise boosts healthy brain aging, study finds

    Colorado State University, July 26, 2021

    Neuroscientists have long known that aerobic exercises, like walking, swimming, running, or biking, are largely beneficial for brain health. Now, new research out of Assistant Professor Aga Burzynska’s BRAiN Lab at Colorado State University provides some of the first evidence that white matter, which connects and carries signals between neurons, can also change for the better in response to aerobic exercise, giving a boost to participants’ memory recall.

    The study, published in NeuroImage on June 24, found that regions of the brain most vulnerable to aging were also the regions that benefitted most from , suggesting that regular aerobic exercise is an effective strategy to reduce the risk of cognitive decline in a world where the incidence of dementia is expected to double every 20 years as the population ages.

    White matter vs. gray matter

    White matter is commonly regarded as a passive brain tissue that takes a backseat to its active, gray matter counterpart, where powerful neurons live. If neurons are the brain cells that generate signals and electrical impulses, then axons in white matter are the wiring that transmit those signals between neurons.

    White matter is mostly made up of the brain’s axon wiring; it received its “white” namesake due to the fatty proteins and lipids that coat the axon fibers. The insulation provided by those proteins and lipids helps to increase the speed at which signals can be passed from one brain region to another.

    While neurodegeneration is often associated with a loss of neurons with age, and therefore a loss of gray matter, aging white matter can also impair cognitive health. A reduction in axon fibers, as well as lesions and microbleeds, are associated with age-related deficits in brain function; thus, interventions to prevent white matter aging are also important to the prevention of Alzheimer’s disease and other dementias.

    A test of exercise

    In Burzynska’s latest study, her team gathered a sample of 180 older adults who were healthy, but admittedly inactive—the ideal population to study when developing a baseline of how effective exercise can be.

    “We decided to include healthy participants so that we can first understand what’s ‘more normal’ in healthy aging and further apply this knowledge later on in other populations, such as people with dementia,” said Andrea Mendez Colmenares, Burzynska’s graduate student and first author on the study.

    Participants were then randomly separated into groups that met three times per week over the course of six months. One group walked for about 40 minutes at each session. Another group took a dance class that got progressively harder over the course of six months. And the final group, which acted as a control for the study, was limited to balance and stretch exercises that purposely aimed to keep their heart rates low.

    Each participant underwent a series of magnetic resonance imaging and cognitive and cardiorespiratory testing before and after the intervention to assess the effects of  on the brain.

    Cutting-edge techniques

    To gauge the change in white matter over time, the team employed a technique called the T1w/T2w ratio, which involved MRI scans of the participants’ brains.

    When MRI scans are taken, most often researchers and doctors are looking at T1-weighted and T2-weighted images. These are the black, white, and gray images of the brain often seen on TV medical dramas when the character’s brain is injured. In a T1-weighted image, white matter of the brain appears white, and appears gray, but on a T2-weighted image, the colors are inverted. It’s the coloring that helps researchers identify changes in brain anatomy, such as tumors, atrophy, or in this case, changes in white matter.

    Since T1-w and T2-w images are widely available in most research studies, the team decided to combine the images to create a ratio to enhance the contrast that refers to the white matter of the brain. Using algorithms and advanced statistics, the team was able to extract values that show how specific regions of white matter changed over the course of the six-month intervention.

    Mendez Colmenares also employed other white matter metrics using the more common technique of diffusion weighted imaging and by studying brain volume and lesions on the brain. Together, the metrics used led to one of the most comprehensive studies of white matter to date.

    Increased white matter

    Using the T1w/T2w ratio technique, the team found that participants in the walking and dance groups had an increase in their white matter after six months of aerobic exercise.

    In other words, physical activity positively affected the brain’s white matter, but especially in regions most vulnerable to aging, such as the corpus callosum and cingulum, which confer important cognitive abilities, such as memory and executive function.

    Further, the walking group experienced the added benefit of improved episodic memory after the intervention and were more able to recall memories from their lifetimes.

    “This might be because the walking group had more people versus the dancing group, but we have strong reasons to believe this may be because the walking group had a stronger aerobic component, like they and their hearts were working harder,” Mendez Colmenares said.

    Thus, activities that really raise the heart rate might be better equipped to combat certain side effects of brain aging.

    However, the opposite is true of activities that aren’t as vigorous: Participants in the team’s study who were limited to low-intensity exercises, such as stretching or balancing postures, experienced a normal, slow decline in white matter signal over six months, and no changes in episodic memory.

    A little goes a long way

    Taken together, the results support public health recommendations for regular moderate-to-vigorous physical activity, specifically 150 minutes of physical activity per week, according to the American Heart Association and other health organizations.

    Further, the findings strengthen the idea that white matter is “plastic” and able to change as a result of experience or intervention, even in the short-term—some positive news for those who might be looking to add more exercise to their lifestyles.

    “The fact that we were able to show results in white matter in a clinical trial in only six months means that you don’t need to exercise your entire life to show some changes in your brain,” Mendez Colmenares said.

    Mendez Colmenares added that she hopes this research paves the way for personalized recommendations in the future that tailor  to what works best for each individual, based on their own biology and physiology.

    “We hope this can advance the field of white matter aging and dementia in the way that more recommendations for non-pharmacological treatments and lifestyle interventions can be better directed to people who are aging normally, and to people who have some impairment, so that people can live independently for longer and with better cognition,” she said.

    Moving forward, Burzynska’s BRAiN Lab is drilling down into other, more advanced white matter techniques to help verify the findings and better understand the mechanisms controlling  alterations in the .

    And, as is the way of science, it’s now up to other researchers to test the team’s findings and see if they can replicate similar results.